Keane Capital Partners Lowers stake in Cooper Companies Inc (COO)

Cooper Companies Inc (COO) : Keane Capital Partners reduced its stake in Cooper Companies Inc by 27.27% during the most recent quarter end. The investment management company now holds a total of 16,000 shares of Cooper Companies Inc which is valued at $2,722,080 after selling 6,000 shares in Cooper Companies Inc , the firm said in a disclosure report filed with the SEC on Nov 14, 2016.Cooper Companies Inc makes up approximately 4.90% of Keane Capital Partners’s portfolio.

Other Hedge Funds, Including , Blue Jay Capital Management sold out all of its stake in COO during the most recent quarter. The investment firm sold 92,690 shares of COO which is valued $16,709,226.Los Angeles Capital Management Equity Research Inc reduced its stake in COO by selling 100 shares or 1.99% in the most recent quarter. The Hedge Fund company now holds 4,934 shares of COO which is valued at $896,804. Cooper Companies Inc makes up approx 0.01% of Los Angeles Capital Management Equity Research Inc’s portfolio.Manning Napier Advisors reduced its stake in COO by selling 208,084 shares or 36.96% in the most recent quarter. The Hedge Fund company now holds 354,911 shares of COO which is valued at $61,672,884. Cooper Companies Inc makes up approx 0.39% of Manning Napier Advisors’s portfolio.

Cooper Companies Inc closed down -2.4 points or -1.38% at $172 with 3,49,569 shares getting traded on Monday. Post opening the session at $174.27, the shares hit an intraday low of $171.86 and an intraday high of $175.26 and the price fluctuated in this range throughout the day.Shares ended Monday session in Red.

On the company’s financial health, Cooper Companies Inc reported $2.30 EPS for the quarter, beating the analyst consensus estimate by $ 0.01 according to the earnings call on Sep 1, 2016. Analyst had a consensus of $2.29. The company had revenue of $514.70 million for the quarter, compared to analysts expectations of $512.63 million. The company’s revenue was up 11.5% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.97 EPS.

Many Wall Street Analysts have commented on Cooper Companies Inc. Company shares were Reiterated by BMO Capital Markets on Sep 2, 2016 to “Outperform”, Firm has raised the Price Target to $ 206 from a previous price target of $199 .Company shares were Reiterated by Stifel on Aug 31, 2016 to “Buy”, Firm has raised the Price Target to $ 215 from a previous price target of $195 .

The Cooper Companies Inc. (Cooper) is a global medical device company. The Company operates through two business units CooperVision Inc. (CVI) and CooperSurgical Inc. (CSI). CooperVision is a global manufacturer providing products for contact lens wearers. CooperSurgical focuses on supplying women’s health clinicians with products and treatment options to improve the delivery of healthcare to women. CooperSurgical products fall into three main segments based on the point of healthcare delivery: Hospital Office and Fertility Clinic. CooperVision develops manufactures and markets a range of monthly two-week and single-use contact lenses featuring advanced materials and optics. CooperVision is involved in correcting vision problems such as astigmatism presbyopia and ocular dryness and provides innovative contact lens solutions. The CooperVision Company’s brands include Biofinity Avaira and MyDay and CooperSurgical Company’s brands include Advincula Arch SeeClear and Mobius.

Leave a Reply

Cooper Companies Inc - Is it time to Sell?

Top Brokerage Firms are advising their investors on Cooper Companies Inc. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.